Format

Send to

Choose Destination
Pigment Cell Melanoma Res. 2016 Jan;29(1):101-3. doi: 10.1111/pcmr.12394. Epub 2015 Aug 20.

A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma.

Author information

1
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
2
Sarah Cannon Research Institute and Tennessee Oncology PLLC, Nashville, TN, USA.
3
Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA.
4
Division of Surgical Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
PMID:
26176864
DOI:
10.1111/pcmr.12394
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center